Methods for producing an etch resist pattern on a metallic surface
US-2024035167-A1 · Feb 1, 2024 · US
US9284648B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9284648-B2 |
| Application number | US-201213447873-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 16, 2012 |
| Priority date | Apr 27, 2011 |
| Publication date | Mar 15, 2016 |
| Grant date | Mar 15, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention describes a method and compositions where the presence of cobalt and or nickel have been depleted from the surface layer(s) of a cobalt, chromium, nickel containing alloy.
Opening claim text (preview).
What is claimed is: 1. A treated alloy composition comprising cobalt, nickel, molybdenum and chromium, wherein the alloy surface has increased concentrations of molybdenum and chromium within at least the first 2 nm of the depth of the surface, wherein the alloy surface concentration of molybdenum is from about 2.2 atomic percent to about 3.9 atomic percent and the concentration of chromium is from about 10.4 atomic percent to about 17.5 atomic percent. 2. The treated alloy composition of claim 1 , wherein the alloy surface has increased concentrations of molybdenum and chromium within the first 5 nm of the depth of the surface. 3. The treated alloy composition of claim 2 , wherein the alloy surface has increased concentrations of molybdenum and chromium at least 10 nm in depth. 4. The treated alloy composition of claim 1 , wherein the alloy is configured as a spring or an electrical lead. 5. The treated alloy composition of claim 4 , wherein the spring or electrical lead is in a medical device. 6. The treated alloy composition of claim 5 , wherein the medical device is a drug pump. 7. The treated alloy composition of claim 1 , wherein the alloy surface is pretreated with an alkaline aqueous solution containing about 0.01 percent to about 10 percent surfactants and chelating agents by weight. 8. A treated alloy composition comprising cobalt, nickel, molybdenum and chromium, wherein the alloy surface has increased concentrations of molybdenum and chromium, wherein the alloy surface concentration of molybdenum is from about 2.2 atomic percent to about 3.9 atomic percent and the concentration of chromium is from about 10.4 atomic percent to about 17.5 atomic percent, and wherein the alloy releases less than 1 ng/mm 2 of cobalt or nickel over a 16 week period at 37° C. in an aqueous nitric acid solution at a pH of 2.2. 9. The treated alloy composition of claim 8 , wherein the alloy surface is treated with about 15 to about 30 percent nitric acid by volume at a temperature of from about 40° C. to about 100° C. for a period of time from about 60 minutes to about 180 minutes. 10. The treated alloy composition of claim 8 , wherein the treated surface of has increased concentrations of molybdenum and chromium through a depth of about 2 nm from the surface of the alloy. 11. The treated alloy composition of claim 8 , wherein the treated surface has increased concentrations of molybdenum and chromium through a depth of about 5 nm of the surface of the alloy. 12. The treated alloy composition of claim 11 , wherein the alloy surface has increased concentrations of molybdenum and chromium at least 10 nm in depth. 13. The treated alloy composition of claim 8 , wherein the alloy is configured as a spring or an electrical lead. 14. The treated alloy composition of claim 13 , wherein the spring or electrical lead is in a medical device. 15. The treated alloy composition of claim 14 , wherein the medical device is a drug pump. 16. A method to modify a surface of a cobalt, nickel, molybdenum and chromium alloy as claimed in claim 1 , wherein the alloy surface is treated to have increased concentrations of molybdenum and chromium, wherein the alloy surface concentration of molybdenum is from about 2.2 atomic percent to about 3.9 atomic percent and the concentration of chromium is from about 10.4 atomic percent to about 17.5 atomic percent, comprising the step: treating the alloy with about 15 to about 30 percent nitric acid by volume at a temperature of from about 40° C. to about 100° C. for a period of time from about 60minutes to about 180 minutes. 17. The method of claim 16 , further comprising the step of rinsing the alloy surface with water after the nitric acid treatment. 18. The method of claim 16 , wherein the surface of the alloy releases less than 1 ng/mm 2 cobalt or nickel over a 16 week period at 37 ° C. in an aqueous nitric acid solution at a pH of 2.2. 19. The method of claim 16 , wherein the surface has increased concentrations of molybdenum and chromium through a depth of about 10 nm of the surface of the alloy. 20. The method of claim 16 , wherein the surface has increased concentrations of molybdenum and chromium through a depth of about 5nm of the surface of the alloy. 21. The method of claim 20 , wherein the surface has increased concentrations of molybdenum and chromium to at least 2 nm in depth. 22. The method of claim 16 , further comprising the step: pretreating the alloy surface with an alkaline aqueous solution containing about 0.01 percent to about 10 percent surfactants and chelating agents by weight at a temperature of from about 37° C. to about 71° C. for a period of time from about 30 minutes to about 120 minutes.
Materials characterised by their function or physical properties {, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials} · CPC title
Cobalt or cobalt alloys · CPC title
Modification of implant surfaces in order to improve biocompatibility, cell growth, fixation of biomolecules, e.g. plasma treatment · CPC title
Etching metallic material by chemical means (manufacture of printing surfaces B41C; manufacture of printed circuits H05K) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.